We are pleased to announce the signing of an agreement with AstraZeneca for the provision of biosafety, quality control and analytical testing services in support of AZD1222 – a COVID-19 vaccine candidate co-invented by the University of Oxford and its spin-out company, Vaccitech and licensed by AstraZeneca. Read more
|